Original articles and reviews
最新の情報はGoogle Scholarをご覧ください： リンク
[1] T. Vogel, S. Kohlmann, Z. Abboud, S. Thusek, F. Fella, J. Teßmar, K. Sekimizu, A. Miyashita, A. Beilhack, and J. Groll, Beyond the Charge: Interplay of Nanogels’ Functional Group and Zeta‐Potential for Antifungal Drug Delivery to Human Pathogenic Fungus Aspergillus fumigatus. Macromolecular Bioscience (2024) 2400082.
[2] A. Miyashita, M. Miyauchi, and F. Tabuchi, The prospects of automation in drug discovery research using silkworms. Drug Discoveries & Therapeutics 18 (2024) 130-133.
[3] A. Miyashita, K. Mikami, M. Ishii, M. Miyauchi, and F. Tabuchi, Advancing microbial isolation: The impact of leaf mold extract agar on soil samples. bioRxiv (2024) 2024.03. 15.585253.
[4] A.E. Nabbout, L.V. Ferguson, A. Miyashita, and S.A. Adamo, Female ticks (Ixodes scapularis) infected with Borrelia burgdorferi have increased overwintering survival, with implications for tick population growth. Insect Science in press (2023).
[5] A. Miyashita, K. Kataoka, T. Tsuchida, A.A. Ogasawara, H. Nakajima, M. Takahashi, and K. Sekimizu, High molecular weight glucose homopolymer of broccoli (Brassica oleracea var. italica) stimulates both invertebrate and mammalian immune systems. Frontiers in Food Science and Technology 3 (2023).
[6] A. Miyashita, K. Sekimizu, and C. Kaito, Surrounding gas composition affects the calling song development in the two-spotted cricket (Gryllus bimaculatus). Drug Discoveries & Therapeutics advpub (2022).
[7] A. Miyashita, S. Mitsutomi, T. Mizushima, and K. Sekimizu, Repurposing the PDMA-approved drugs in Japan using an insect model of staphylococcal infection. FEMS Microbes 3 (2022).
[8] W. Li, A. Miyashita, and K. Sekimizu, Peanut triacylglycerols activate innate immunity both in insects and mammals. Scientific Reports 12 (2022) 1-9.
[9] H. Hamamoto, A. Miyashita, K. Kamura, R. Horie, and K. Sekimizu, Silkworm arylsulfatase in the midgut content is expressed in the silk gland and fed <i>via</i> smearing on the food from the spinneret. Drug Discoveries & Therapeutics 16 (2022) 280-285.
[10] A. El Nabbout, L. Ferguson, A. Miyashita, and S. Adamo, Adult ticks ( Ixodes scapularis ) infected with B. burgdorferi have increased overwintering survival, with implications for tick population growth. bioRxiv (2022).
[11] H. Nakajima, A. Miyashita, H. Hamamoto, and K. Sekimizu, A novel application of bubble-eye strain of Carassius auratus for ex vivo fish immunological studies. Sci Rep 11 (2021) 10757.
[12] A. Miyashita, K. Shimomura, H. Nakajima, Y. Matsumoto, and K. Sekimizu, A digital scheme of human trials for the evaluation of functional foods. Drug Discov Ther 15 (2021) 9-13.
[13] A. Miyashita, and K. Sekimizu, Using silkworms to search for lactic acid bacteria that contribute to infection prevention and improvement of hyperglycemia. Drug Discoveries & Therapeutics 15 (2021) 51-54.
[14] A. Miyashita, K. Kataoka, T. Tsuchida, A.A. Ogasawara, H. Hamamoto, M. Takahashi, and K. Sekimizu, Purification of immunostimulatory glucose homopolymer from broccoli (<em>Brassica oleracea</em> var. italica). bioRxiv (2021) 2021.05.26.445781.
[15] A. Miyashita, K. Kataoka, and K. Sekimizu, Activation of innate immunity by neutral polysaccharides from broccoli buds. bioRxiv (2021).
[16] A. Miyashita, H. Hamamoto, and K. Sekimizu, Applying the silkworm model for the search of immunosuppressants. Drug Discov Ther 15 (2021) 139-142.
[17] H. Hamamoto, S. Panthee, A. Paudel, K. Ishii, J. Yasukawa, J. Su, A. Miyashita, H. Itoh, K. Tokumoto, M. Inoue, and K. Sekimizu, Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus. Nat Commun 12 (2021) 6364.
[18] A. Miyashita, T.Y.M. Lee, and S.A. Adamo, High-Stakes Decision-Making by Female Crickets (Gryllus texensis): When to Trade In Wing Muscles for Eggs. Physiol Biochem Zool 93 (2020) 450-465.
[19] A. Miyashita, and S.A. Adamo, Stayin’alive: endocrinological stress responses in insects, Advances in invertebrate (neuro) endocrinology, Apple Academic Press, 2020, pp. 283-323.
[20] C. Kaito, H. Yoshikai, A. Wakamatsu, A. Miyashita, Y. Matsumoto, T. Fujiyuki, M. Kato, Y. Ogura, T. Hayashi, T. Isogai, and K. Sekimizu, Non-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter. PLoS Pathog 16 (2020) e1008469.
[21] A. Miyashita, T.Y.M. Lee, L.E. McMillan, R. Easy, and S.A. Adamo, Immunity for nothing and the eggs for free: Apparent lack of both physiological trade-offs and terminal reproductive investment in female crickets (Gryllus texensis). Plos One 14 (2019) e0209957.
[22] A. Miyashita, T.Y.M. Lee, L.E. McMillan, R. Easy, and S. Adamo, Terminal Reproductive Investment, Physiological Trade-offs and Pleiotropic Effects: Their effects produce complex immune/reproductive interactions in the cricket Gryllus texensis. bioRxiv (2018) 499236.
[23] A. Miyashita, Calling song maturity in two-spotted cricket, Gryllus bimaculatus: its patterns and a possible physical explanation. bioRxiv (2017) 207712.
[24] A. Miyashita, A fast immune priming that confers a complete infection resistance on silkworm (Bombyx mori). bioRxiv (2017) 205369.
[25] A. Miyashita, H. Kizaki, K. Sekimizu, and C. Kaito, Body-enlarging effect of royal jelly in a non-holometabolous insect species, Gryllus bimaculatus. Biol Open 5 (2016) 770-6.
[26] A. Miyashita, H. Kizaki, K. Sekimizu, and C. Kaito, No Effect of Body Size on the Frequency of Calling and Courtship Song in the Two-Spotted Cricket, Gryllus bimaculatus. Plos One 11 (2016) e0146999.
[27] Y. Kochi, A. Miyashita, K. Tsuchiya, M. Mitsuyama, K. Sekimizu, and C. Kaito, A human pathogenic bacterial infection model using the two-spotted cricket, Gryllus bimaculatus. Fems Microbiology Letters 363 (2016) fnw163.
[28] K. Imae, Y. Saito, H. Kizaki, H. Ryuno, H. Mao, A. Miyashita, Y. Suzuki, K. Sekimizu, and C. Kaito, Novel Nucleoside Diphosphatase Contributes to Staphylococcus aureus Virulence. J Biol Chem 291 (2016) 18608-18619.
[29] A. Miyashita, S. Takahashi, K. Ishii, K. Sekimizu, and C. Kaito, Primed Immune Responses Triggered by Ingested Bacteria Lead to Systemic Infection Tolerance in Silkworms. PLoS One 10 (2015) e0130486.
[30] A. Miyashita, Y. Hirai, K. Sekimizu, and C. Kaito, Antibiotic-producing bacteria from stag beetle mycangia. Drug Discov Ther 9 (2015) 33-7.
[31] A. Miyashita, H. Kizaki, K. Kawasaki, K. Sekimizu, and C. Kaito, Primed immune responses to gram-negative peptidoglycans confer infection resistance in silkworms. J Biol Chem 289 (2014) 14412-21.
[32] A. Miyashita, S. Iyoda, K. Ishii, H. Hamamoto, K. Sekimizu, and C. Kaito, Lipopolysaccharide O-antigen of enterohemorrhagic Escherichia coli O157:H7 is required for killing both insects and mammals. Fems Microbiology Letters 333 (2012) 59-68.